XML 43 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Share-based Compensation (Tables)
9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Summary of allocation of share-based compensation expenses
The table below sets forth the allocation of share-based compensation expenses:
 
    
For the nine months ended

September 30,
 
    
2019
    
2020
 
    
RMB
    
RMB
 
Research and development expenses
     1,061        11,577  
General and administrative expenses
     2,302        7,658  
Cost of revenues
     1,447        3,876  
Sales and marketing expenses
     688        3,790  
    
 
 
    
 
 
 
Total
  
 
5,498
 
  
 
26,901
 
    
 
 
    
 
 
 
Schedule of share based payment award stock options valuation assumptions The fair value of each option granted for the nine months ended September 30, 2019 and 2020 is estimated on the date of grant using the following assumptions:
 
    
For the nine months ended

September 30,
 
    
2019
    
2020
 
Expected volatility
    
46.50%-46.90%
      
48.90%-52.20%
 
Expected dividends yield
     0%        0%  
Risk-free interest rate
    
2.10%-2.60%
      
0.30%-1.69%
 
Expected term (in years)
     6        6  
Fair value of underlying ordinary share (US$)
    
6.35-7.29
      
16.00-42.31
 
Schedule of share based compensation stock option activity
The following table presents a summary of the Company’s options activities for the nine months ended September 30, 2019 and 2020:
 
    
Number of
options
    
Weighted
average exercise
price per share
    
Weighted average
remaining
contractual life
    
Aggregate
intrinsic
value
 
    
(in thousands)
    
US$
    
Years
    
US$
 
Outstanding as of January 1, 2019
     6,991        2.13        3.40        29,468  
Granted
     2,072        3.50                    
Forfeited
     (626      2.52                    
    
 
 
                            
Outstanding as of September 30, 2019
     8,437        2.44        3.30        40,906  
    
 
 
                            
Outstanding as of January 1, 2020
     8,329        2.43        3.06        97,000  
Granted
     888        4.00                    
Exercised
     (1,987      1.93                    
Forfeited
     (247      2.89                    
    
 
 
                            
Outstanding as of September 30, 2020
     6,983        2.76        2.98        161,159  
    
 
 
                            
Vested and exercisable as of September 30, 2019
     —                             
Vested and exercisable as of September 30, 2020
     3,156        2.12        1.70        74,874